STOCK TITAN

Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Silk Road Medical (Nasdaq: SILK) will report its second quarter 2022 financial results on July 26, 2022, after market close. An audio webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET. The company focuses on reducing stroke risk with its TransCarotid Artery Revascularization (TCAR) procedure, which combines neuroprotection and minimally invasive techniques. For more details, visit their website or register for the event online.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2022 after market close on Tuesday, July 26, 2022. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at https://investors.silkroadmed.com.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com 


FAQ

When will Silk Road Medical report its Q2 2022 financial results?

Silk Road Medical will report its Q2 2022 financial results after market close on July 26, 2022.

What time will the Silk Road Medical audio webcast start?

The audio webcast will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on July 26, 2022.

What is Silk Road Medical's focus in the medical device market?

Silk Road Medical focuses on reducing the risk of stroke, primarily through its TransCarotid Artery Revascularization (TCAR) procedure.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
38.94M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE